News for Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals' Soquelitinib shows promise for PTCL & more, but financial risks and competition raise concerns. Learn more about CRVS stock here.

On December 31, 2024, Samlyn Capital, LLC executed a significant transaction by acquiring an additional 2,136,772 shares of Corvus Pharmaceuticals Inc. This acq

On December 31, 2024, ADAMS STREET PARTNERS LLC (Trades, Portfolio) made a strategic decision to reduce its position in Mineralys Therapeutics Inc (MLYS) by 402

**media[513456,513457]**

BURLINGAME, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. ( CRVS), a clinical-stage biopharmaceutical company, today announced that R

Corvus Pharmaceuticals (CRVS) stock was granted a new buy recommendation by H.C. Wainwright based on its lead asset, despite its recent selloff. Read more here.

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in the $22.6B Atopic Dermatitis market.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Wednesday. The Dow traded up 0.52% to 43,674.00 while t...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded...

Corvus Pharmaceuticals, Inc. (CRVS), Wednesday announced interim data from phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis, a chronic disease.

Corvus Pharmaceuticals (CRVS) stock plunges 33% after Phase 1 trial results for soquelitinib in eczema. Read more here.

U.S. stock futures were lower this morning, with the Dow futures falling around 150 points on Tuesday. Shares of HEICO Corporation HEI fell sharply in today's ...

U.S. stock futures climbed on Wednesday as Wall Street awaits the Fed's final interest rate decision and its monetary policy forecasts for 2025.

Shares of Corvus Pharmaceuticals, Inc. CRVS rose sharply in today's pre-market trading after the company announced it will report on December 18 interim data fr...

The exosome market is fueled by several significant factors, such as the rising incidence of chronic diseases, improvements in diagnostic methods, and...

U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Monday. Shares of Stellantis N.V. STLA fell sharply in toda...

Shares of NIO Inc. NIO rose sharply in today's pre-market. Nio announced Sunday that strategic investors, including Hefei Jianheng New Energy Automobile Invest...

U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Wednesday. Shares of Casella Waste Systems, Inc. CWST fell sharpl...

These stocks are making interesting moves on high volume. Active Stocks Moving Up Today QuickLogic Corporation (QUIK) < (QUIK) is currently trading at $6....